Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-18

Clinical Trial Update: Toronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on photobiomodulation for nonexudative age-related macular degeneration, with completion reported from sites in Toronto and Oak Ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Merry, Graham, M.D. | Conditions: Nonexudative Age-related Macular Degeneration | Phase 2 | Status: COMPLETED